Careful investigation of a rare disease: insights into multiple endocrine neoplasia type 2B
Author:
- 16 January 2019
- journal article
- editorial
- Published by Elsevier in The Lancet Diabetes & Endocrinology
- Vol. 7 (3) , 167-168
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Multiple Endocrine Neoplasia Type 2B Presents Early in Childhood but Often Is Undiagnosed for YearsThe Journal of Pediatrics, 2018
- Selective RET kinase inhibition for patients with RET-altered cancersAnnals of Oncology, 2018
- Pediatric thyroid cancer patients referred to high-volume facilities have improved short-term outcomesSurgery, 2018
- Long-Term Survivorship in Multiple Endocrine Neoplasia Type 2B Diagnosed Before and in the New MillenniumThe Journal of Clinical Endocrinology & Metabolism, 2017
- Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid CarcinomaThyroid®, 2015
- Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based studyThe Lancet Oncology, 2014
- Hereditary Medullary Thyroid Cancer: Age-Appropriate Thyroidectomy Improves Disease-Free SurvivalAnnals of Surgical Oncology, 2012
- Prognosis of medullary thyroid carcinomaCancer, 2006
- Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumoursHuman Molecular Genetics, 1994
- Mutations in the RET proto-oncogene are associated with MEN 2A and FMTCHuman Molecular Genetics, 1993